Trial
NCT04387071
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Condition
Locally Advanced Malignant Solid Neoplasm
Intervention
Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
Why stopped
Study drug no longer available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-17